... associated with implanted pacemakers and cardioverter defibrillators.
Dr. David Delurgio, ... following the implantation of pacemakers or cardioverter defibrillators," stated Dr. Delurgio. "The ... to securely hold a pacemaker or implantable cardioverter defibrillator (ICD) in order to create a stable ...

... The study also found that doctors rarely discuss deactivating implantable cardioverter defibrillators with very sick heart failure patients and their families.
Implantable cardioverter defibrillators detect cardiac arrhythmias and correct the condition by ...

... of $3.4 billion in 2008 and is estimated to reach $7.3 billion in 2015. The following segments are covered in this research: pacemakers, implantable cardioverter defibrillators, cardiac resynchronisation devices and ablation catheters and pacing leads.
If you are interested in a virtual brochure, which ...

... Heart patients gained an extra year of life over 8 years of follow-up, study finds,,,,
THURSDAY, May 14 (HealthDay News) --Implanted cardioverter defibrillators (ICDs) extend heart patients' lives even eight years after implantation, new research shows.
The finding was to be presented ...

... week from the University of Notre Dame , born with a congenital heart defect that severely worsened in high school. Olivia required an implantable cardioverter defibrillator (ICD) in 2005.
The patients emphasized how critical it was for them to have access to devices when they needed ...

... associated with implanted pacemakers and cardioverter defibrillators. AIGIS also securely holds a pacemaker (PM) or implantable cardioverter defibrillator (ICD) in order to create a stable ... to securely hold a pacemaker or implantable cardioverter defibrillator (ICD) in order to create a stable ...

... to be associated with a significant 29 percent reduction (p=0.003) in death or heart failure interventions when compared to traditional implantable cardioverter defibrillators (ICDs). High risk(1), asymptomatic or mildly symptomatic, New York Heart Association (NYHA) Class I and II(2) patients were enrolled ...

... BSX ) today announced that an analysis of long-term data from the MADIT II clinical study demonstrates that the life-saving benefits of implantable cardioverter defibrillator (ICD) therapy remain sustainable at eight years. This is the first time long-term data have been presented regarding the life-saving ...

... (NYSE: BSX ) today announced CE Mark approval for its COGNIS(TM)
cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN(TM)
implantable cardioverter defibrillator (ICD). These devices represent
entirely new platforms to treat heart failure and sudden cardiac death and
are the result of a ...

Description:... Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (SCD), and have been found to reduce the SCD mortality rate for these patients ...Company:Guidant Corporation

Description:... The Guidant VITALITY 2 implantable cardioverter defibrillators (ICDs) are designed to treat patients at risk for sudden cardiac death (SCD) due to arrhythmia. The size and physiologic shape of the ...Company:Guidant Corporation

Description:... Implantable defibrillators are used to treat heart rhythms that are abnormally fast and life threatening. Implantable cardioverter defibrillators (ICDs) often are used to treat sudden cardiac death (SCD), and have been found to reduce the SCD mortality rate for these patients ...Company:Guidant Corporation

...
In a systematic review of trials where patients with implantable cardioverter defibrillators used fish oil supplements, Dr. David Jenkins and Dr. Paul ... stable angina. The same may also be true for patients with implantable cardioverter defibrillators who have a history of ventricular tachycardia and who are ...

... been limited to two medications beta blockers, often used at very high doses, and calcium channel blockers to control the arrhythmias. Implantable cardioverter defibrillators (ICDs) are placed in patients at high risk for sudden death, but ongoing arrhythmias can result in frequent stressful shocks.
The ...

... This year, Medicare will pay for tens of thousands of heart patients to have high-tech devices implanted in their chests. Called ICDs or implantable cardioverter defibrillators, the expensive devices are designed to shock damaged hearts back into rhythm and save patients from sudden cardiac death, which kills ...

... use them to identify those people for whom defibrillators are more likely to worsen abnormal heart rate, Bursac said.
So-called implantable cardioverter defibrillators (ICD) monitor the timing of heartbeats and can deliver small or large shocks to correct arrhythmias. Such devices have become ...

... if the device malfunctions, e.g., battery failure.
When a patient's status changes, a built-in microchip of Biotronik's Lumos DR-T implantable cardioverter defibrillator (ICD) sends a signal to a satellite via a small transmitter that can be placed on a nightstand, worn on a belt or kept in a purse. In ...

... I heart failure patients.
The international version of the LATITUDE system is compatible with the Company's wireless TELIGEN(R) implantable cardioverter defibrillator (ICD) and COGNIS(R) cardiac resynchronization therapy defibrillator (CRT-D), the world's smallest and thinnest high-energy devices.
...

(Date:3/31/2015)... YORK , March 31, 2015 Guidepoint ... the launch of the Post-Surgical Pain Management TRACKER, part ... products tracking usage trends in the medical device and ... access to data including treatment volumes, market share, and ... the pain associated with joint surgery. The ...

(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...